Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Goodleaf was a South African wellness company and premium CBD brand focused on over-the-counter cannabidiol products rather than prescription therapeutics. Its product portfolio included CBD drops, vapes, sachets, beverages, skincare products, and related wellness offerings marketed for general wellbeing and symptom relief. The company also appears to have expanded its wellness positioning into adaptogen and functional mushroom products through the Goodmind brand in collaboration with Psyence. Based on available evidence, Goodleaf operated commercially in South Africa but does not appear to have run a traditional biotech or drug-development pipeline. Public insolvency-related records indicate that The Goodleaf Company (Pty) Ltd entered liquidation in 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Goodleaf.